United States · 
Who invested in PathogenDx?
PathogenDx's investors include Cresco Capital Partners, Salveo Capital, Panther Opportunity Fund and Flatiron Venture Partners. Cresco Capital Partners led its latest round.
United States · Series B startup
Who invested in PathogenDx
Funding summaryUpdated 26 Oct 2026
$7.5Mraised across 1 round since 2019, from 1 source
- Latest round
- Series B, $7.5MSept 2019
- Led by
- Cresco Capital Partners
- Investors
- 4 (1 led)
The rounds
- Sept 2019Series B$7.5M
Reported by FinSMEs
Founders and team
From PathogenDx's own website and the SEC filings it signed: 3 founders, 1 on the team.
Milan PatelCo-Founder and CEONamed on its 2016 Form D
Michael Hogan Ph.D.Co-Founder and Chief Scientific Officer
Eric LachanceCo-FounderNamed on its 2016 Form D
- Michael HoganCSOi
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about PathogenDx
How much has PathogenDx raised?
PathogenDx has raised $7.5M across 1 round since 2019.
When did PathogenDx last raise?
PathogenDx's most recent round was a Series B of $7.5M in Sept 2019, led by Cresco Capital Partners.
What was PathogenDx's biggest round?
Its most recent round, $7.5M in Sept 2019, is also its largest on record.
Who backed PathogenDx first?
PathogenDx's first round on record, in Sept 2019, was backed by Cresco Capital Partners, Salveo Capital and Panther Opportunity Fund and 1 others.
What stage is PathogenDx at?
PathogenDx's latest named round is a Series B, in Sept 2019.
Where is PathogenDx based?
PathogenDx is based in the United States.
Who led PathogenDx's rounds?
Cresco Capital Partners led the Series B in 2019.
Companies like PathogenDx
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.